Why Did BioNexus Gene Lab Plunge 9.09% After Reverse Split?

On July 3, 2025, BioNexus Gene Lab experienced a 9.09% drop in pre-market trading, marking a notable shift in its stock performance.

BioNexus Gene Lab recently conducted a 1 for 10 reverse stock split, which means shareholders now hold 1 share for every 10 shares they previously owned. This corporate action is aimed at increasing the stock price and potentially attracting more investors by making the shares more valuable on a per-share basis.

Prior to the recent drop, BioNexus Gene Lab had seen substantial gains, with its stock price surging by over 200% in previous trading sessions. This volatility reflects the company's dynamic market position and the potential for significant price movements based on investor sentiment and market conditions.